id	sid	tid	token	lemma	pos
dpc-1006	1	1	dermatology	dermatology	NOUN
dpc-1006	1	2	:	:	PUNCT
dpc-1006	1	3	practical	practical	ADJ
dpc-1006	1	4	and	and	CCONJ
dpc-1006	1	5	conceptual	conceptual	ADJ
dpc-1006	1	6	320	320	NUM
dpc-1006	1	7	letter	letter	NOUN
dpc-1006	2	1	|	|	ADV
dpc-1006	2	2	dermatol	dermatol	ADJ
dpc-1006	2	3	pract	pract	NOUN
dpc-1006	2	4	concept	concept	NOUN
dpc-1006	2	5	2019;9(4):20	2019;9(4):20	NUM
dpc-1006	2	6	dermatology	dermatology	NOUN
dpc-1006	2	7	practical	practical	ADJ
dpc-1006	2	8	&	&	CCONJ
dpc-1006	2	9	conceptual	conceptual	ADJ
dpc-1006	2	10	introduction	introduction	NOUN
dpc-1006	2	11	pemphigus	pemphigus	NOUN
dpc-1006	2	12	consists	consist	VERB
dpc-1006	2	13	of	of	ADP
dpc-1006	2	14	a	a	DET
dpc-1006	2	15	group	group	NOUN
dpc-1006	2	16	of	of	ADP
dpc-1006	2	17	rare	rare	ADJ
dpc-1006	2	18	autoimmune	autoimmune	ADJ
dpc-1006	2	19	blistering	blister	VERB
dpc-1006	2	20	diseases	disease	NOUN
dpc-1006	2	21	that	that	PRON
dpc-1006	2	22	are	be	AUX
dpc-1006	2	23	typically	typically	ADV
dpc-1006	2	24	characterized	characterize	VERB
dpc-1006	2	25	by	by	ADP
dpc-1006	2	26	the	the	DET
dpc-1006	2	27	appearance	appearance	NOUN
dpc-1006	2	28	of	of	ADP
dpc-1006	2	29	intraepithelial	intraepithelial	ADJ
dpc-1006	2	30	blisters	blister	NOUN
dpc-1006	2	31	on	on	ADP
dpc-1006	2	32	the	the	DET
dpc-1006	2	33	skin	skin	NOUN
dpc-1006	2	34	and/or	and/or	CCONJ
dpc-1006	2	35	mucosa	mucosa	NOUN
dpc-1006	2	36	.	.	PUNCT
dpc-1006	3	1	pemphigus	pemphigus	PROPN
dpc-1006	3	2	vulgaris	vulgaris	NOUN
dpc-1006	3	3	(	(	PUNCT
dpc-1006	3	4	pv	pv	NOUN
dpc-1006	3	5	)	)	PUNCT
dpc-1006	3	6	and	and	CCONJ
dpc-1006	3	7	pemphigus	pemphigus	PROPN
dpc-1006	3	8	foliaceus	foliaceus	NOUN
dpc-1006	3	9	(	(	PUNCT
dpc-1006	3	10	pf	pf	NOUN
dpc-1006	3	11	)	)	PUNCT
dpc-1006	3	12	are	be	AUX
dpc-1006	3	13	2	2	NUM
dpc-1006	3	14	well	well	ADV
dpc-1006	3	15	-	-	PUNCT
dpc-1006	3	16	known	know	VERB
dpc-1006	3	17	forms	form	NOUN
dpc-1006	3	18	of	of	ADP
dpc-1006	3	19	pemphigus	pemphigus	NOUN
dpc-1006	3	20	.	.	PUNCT
dpc-1006	4	1	although	although	SCONJ
dpc-1006	4	2	they	they	PRON
dpc-1006	4	3	have	have	VERB
dpc-1006	4	4	distinct	distinct	ADJ
dpc-1006	4	5	clinicopathological	clinicopathological	ADJ
dpc-1006	4	6	features	feature	NOUN
dpc-1006	4	7	,	,	PUNCT
dpc-1006	4	8	each	each	PRON
dpc-1006	4	9	of	of	ADP
dpc-1006	4	10	these	these	DET
dpc-1006	4	11	conditions	condition	NOUN
dpc-1006	4	12	could	could	AUX
dpc-1006	4	13	switch	switch	VERB
dpc-1006	4	14	to	to	ADP
dpc-1006	4	15	the	the	DET
dpc-1006	4	16	other	other	ADJ
dpc-1006	4	17	.	.	PUNCT
dpc-1006	5	1	the	the	DET
dpc-1006	5	2	köbner	köbner	PROPN
dpc-1006	5	3	phenomenon	phenomenon	NOUN
dpc-1006	5	4	(	(	PUNCT
dpc-1006	5	5	kp	kp	INTJ
dpc-1006	5	6	)	)	PUNCT
dpc-1006	5	7	is	be	AUX
dpc-1006	5	8	described	describe	VERB
dpc-1006	5	9	as	as	ADP
dpc-1006	5	10	the	the	DET
dpc-1006	5	11	appearance	appearance	NOUN
dpc-1006	5	12	of	of	ADP
dpc-1006	5	13	new	new	ADJ
dpc-1006	5	14	lesions	lesion	NOUN
dpc-1006	5	15	in	in	ADP
dpc-1006	5	16	the	the	DET
dpc-1006	5	17	uninvolved	uninvolved	ADJ
dpc-1006	5	18	skin	skin	NOUN
dpc-1006	5	19	as	as	ADP
dpc-1006	5	20	a	a	DET
dpc-1006	5	21	consequence	consequence	NOUN
dpc-1006	5	22	of	of	ADP
dpc-1006	5	23	different	different	ADJ
dpc-1006	5	24	kinds	kind	NOUN
dpc-1006	5	25	of	of	ADP
dpc-1006	5	26	trauma	trauma	NOUN
dpc-1006	5	27	.	.	PUNCT
dpc-1006	6	1	it	it	PRON
dpc-1006	6	2	has	have	AUX
dpc-1006	6	3	been	be	AUX
dpc-1006	6	4	described	describe	VERB
dpc-1006	6	5	in	in	ADP
dpc-1006	6	6	several	several	ADJ
dpc-1006	6	7	skin	skin	NOUN
dpc-1006	6	8	disorders	disorder	NOUN
dpc-1006	6	9	,	,	PUNCT
dpc-1006	6	10	including	include	VERB
dpc-1006	6	11	psoriasis	psoriasis	NOUN
dpc-1006	6	12	,	,	PUNCT
dpc-1006	6	13	vitiligo	vitiligo	VERB
dpc-1006	6	14	,	,	PUNCT
dpc-1006	6	15	lichen	lichen	NOUN
dpc-1006	6	16	planus	planus	NOUN
dpc-1006	6	17	,	,	PUNCT
dpc-1006	6	18	and	and	CCONJ
dpc-1006	6	19	rarely	rarely	ADV
dpc-1006	6	20	pemphigus	pemphigus	X
dpc-1006	6	21	[	[	X
dpc-1006	6	22	1	1	NUM
dpc-1006	6	23	]	]	PUNCT
dpc-1006	6	24	.	.	PUNCT
dpc-1006	7	1	here	here	ADV
dpc-1006	7	2	we	we	PRON
dpc-1006	7	3	report	report	VERB
dpc-1006	7	4	a	a	DET
dpc-1006	7	5	patient	patient	NOUN
dpc-1006	7	6	with	with	ADP
dpc-1006	7	7	previously	previously	ADV
dpc-1006	7	8	diagnosed	diagnose	VERB
dpc-1006	7	9	mucocutaneous	mucocutaneous	ADJ
dpc-1006	7	10	pv	pv	INTJ
dpc-1006	7	11	who	who	PRON
dpc-1006	7	12	developed	develop	VERB
dpc-1006	7	13	pf	pf	PROPN
dpc-1006	7	14	after	after	ADP
dpc-1006	7	15	rituximab	rituximab	NOUN
dpc-1006	7	16	(	(	PUNCT
dpc-1006	7	17	rtx	rtx	PROPN
dpc-1006	7	18	)	)	PUNCT
dpc-1006	7	19	therapy	therapy	NOUN
dpc-1006	7	20	and	and	CCONJ
dpc-1006	7	21	developed	develop	VERB
dpc-1006	7	22	crusted	crusted	ADJ
dpc-1006	7	23	lesions	lesion	NOUN
dpc-1006	7	24	some	some	DET
dpc-1006	7	25	weeks	week	NOUN
dpc-1006	7	26	after	after	ADP
dpc-1006	7	27	surgery	surgery	NOUN
dpc-1006	7	28	for	for	ADP
dpc-1006	7	29	femoral	femoral	ADJ
dpc-1006	7	30	avascular	avascular	ADJ
dpc-1006	7	31	necrosis	necrosis	NOUN
dpc-1006	7	32	at	at	ADP
dpc-1006	7	33	the	the	DET
dpc-1006	7	34	surgical	surgical	ADJ
dpc-1006	7	35	site	site	NOUN
dpc-1006	7	36	.	.	PUNCT
dpc-1006	8	1	case	case	NOUN
dpc-1006	8	2	presentation	presentation	NOUN
dpc-1006	8	3	a	a	DET
dpc-1006	8	4	55	55	NUM
dpc-1006	8	5	-	-	PUNCT
dpc-1006	8	6	year	year	NOUN
dpc-1006	8	7	-	-	PUNCT
dpc-1006	8	8	old	old	ADJ
dpc-1006	8	9	man	man	NOUN
dpc-1006	8	10	with	with	ADP
dpc-1006	8	11	an	an	DET
dpc-1006	8	12	8	8	NUM
dpc-1006	8	13	-	-	PUNCT
dpc-1006	8	14	year	year	NOUN
dpc-1006	8	15	history	history	NOUN
dpc-1006	8	16	of	of	ADP
dpc-1006	8	17	mucocutaneous	mucocutaneous	ADJ
dpc-1006	8	18	pv	pv	NOUN
dpc-1006	8	19	(	(	PUNCT
dpc-1006	8	20	confirmed	confirm	VERB
dpc-1006	8	21	with	with	ADP
dpc-1006	8	22	pathological	pathological	ADJ
dpc-1006	8	23	findings	finding	NOUN
dpc-1006	8	24	and	and	CCONJ
dpc-1006	8	25	direct	direct	ADJ
dpc-1006	8	26	immunofluorescence	immunofluorescence	NOUN
dpc-1006	8	27	)	)	PUNCT
dpc-1006	8	28	was	be	AUX
dpc-1006	8	29	treated	treat	VERB
dpc-1006	8	30	with	with	ADP
dpc-1006	8	31	rtx	rtx	PROPN
dpc-1006	8	32	in	in	ADP
dpc-1006	8	33	february	february	PROPN
dpc-1006	8	34	2017	2017	NUM
dpc-1006	8	35	,	,	PUNCT
dpc-1006	8	36	after	after	SCONJ
dpc-1006	8	37	his	his	PRON
dpc-1006	8	38	disease	disease	NOUN
dpc-1006	8	39	had	have	AUX
dpc-1006	8	40	flared	flare	VERB
dpc-1006	8	41	.	.	PUNCT
dpc-1006	9	1	both	both	DET
dpc-1006	9	2	anti	anti	ADJ
dpc-1006	9	3	-	-	ADJ
dpc-1006	9	4	desmoglein	desmoglein	ADJ
dpc-1006	9	5	(	(	PUNCT
dpc-1006	9	6	anti	anti	ADJ
dpc-1006	9	7	-	-	ADJ
dpc-1006	9	8	dsg	dsg	ADJ
dpc-1006	9	9	)	)	PUNCT
dpc-1006	9	10	1	1	NUM
dpc-1006	9	11	and	and	CCONJ
dpc-1006	9	12	anti	anti	ADJ
dpc-1006	9	13	-	-	ADJ
dpc-1006	9	14	dsg3	dsg3	ADJ
dpc-1006	9	15	were	be	AUX
dpc-1006	9	16	positive	positive	ADJ
dpc-1006	9	17	(	(	PUNCT
dpc-1006	9	18	>	>	SYM
dpc-1006	9	19	200	200	NUM
dpc-1006	9	20	u	u	NOUN
dpc-1006	9	21	/	/	SYM
dpc-1006	9	22	ml	ml	ADP
dpc-1006	9	23	)	)	PUNCT
dpc-1006	9	24	at	at	ADP
dpc-1006	9	25	the	the	DET
dpc-1006	9	26	time	time	NOUN
dpc-1006	9	27	of	of	ADP
dpc-1006	9	28	infusion	infusion	NOUN
dpc-1006	9	29	.	.	PUNCT
dpc-1006	10	1	his	his	PRON
dpc-1006	10	2	disease	disease	NOUN
dpc-1006	10	3	went	go	VERB
dpc-1006	10	4	into	into	ADP
dpc-1006	10	5	remission	remission	NOUN
dpc-1006	10	6	within	within	ADP
dpc-1006	10	7	3	3	NUM
dpc-1006	10	8	months	month	NOUN
dpc-1006	10	9	after	after	ADP
dpc-1006	10	10	the	the	DET
dpc-1006	10	11	last	last	ADJ
dpc-1006	10	12	dose	dose	NOUN
dpc-1006	10	13	of	of	ADP
dpc-1006	10	14	rtx	rtx	PROPN
dpc-1006	10	15	and	and	CCONJ
dpc-1006	10	16	remained	remain	VERB
dpc-1006	10	17	on	on	ADP
dpc-1006	10	18	minimal	minimal	ADJ
dpc-1006	10	19	therapy	therapy	NOUN
dpc-1006	10	20	(	(	PUNCT
dpc-1006	10	21	5	5	NUM
dpc-1006	10	22	mg	mg	NOUN
dpc-1006	10	23	prednisolone	prednisolone	PROPN
dpc-1006	10	24	daily	daily	PROPN
dpc-1006	10	25	and	and	CCONJ
dpc-1006	10	26	7.5	7.5	NUM
dpc-1006	10	27	mg	mg	NOUN
dpc-1006	10	28	methotrexate	methotrexate	NOUN
dpc-1006	10	29	weekly	weekly	ADV
dpc-1006	10	30	)	)	PUNCT
dpc-1006	10	31	for	for	ADP
dpc-1006	10	32	more	more	ADJ
dpc-1006	10	33	than	than	ADP
dpc-1006	10	34	a	a	PRON
dpc-1006	10	35	year	year	NOUN
dpc-1006	10	36	.	.	PUNCT
dpc-1006	11	1	in	in	ADP
dpc-1006	11	2	may	may	PROPN
dpc-1006	11	3	2018	2018	NUM
dpc-1006	11	4	he	he	PRON
dpc-1006	11	5	complained	complain	VERB
dpc-1006	11	6	of	of	ADP
dpc-1006	11	7	the	the	DET
dpc-1006	11	8	development	development	NOUN
dpc-1006	11	9	of	of	ADP
dpc-1006	11	10	dry	dry	ADJ
dpc-1006	11	11	lesions	lesion	NOUN
dpc-1006	11	12	on	on	ADP
dpc-1006	11	13	the	the	DET
dpc-1006	11	14	chest	chest	NOUN
dpc-1006	11	15	,	,	PUNCT
dpc-1006	11	16	consistent	consistent	ADJ
dpc-1006	11	17	with	with	ADP
dpc-1006	11	18	pf	pf	PROPN
dpc-1006	11	19	.	.	PUNCT
dpc-1006	11	20	after	after	ADP
dpc-1006	11	21	checking	check	VERB
dpc-1006	11	22	anti	anti	ADJ
dpc-1006	11	23	-	-	ADJ
dpc-1006	11	24	dsg1/3	dsg1/3	ADJ
dpc-1006	11	25	titers	titer	NOUN
dpc-1006	11	26	,	,	PUNCT
dpc-1006	11	27	we	we	PRON
dpc-1006	11	28	found	find	VERB
dpc-1006	11	29	that	that	SCONJ
dpc-1006	11	30	anti	anti	NOUN
dpc-1006	11	31	-	-	NOUN
dpc-1006	11	32	dsg1	dsg1	NOUN
dpc-1006	11	33	was	be	AUX
dpc-1006	11	34	63	63	NUM
dpc-1006	11	35	u	u	NOUN
dpc-1006	11	36	/	/	SYM
dpc-1006	11	37	ml	ml	PROPN
dpc-1006	11	38	,	,	PUNCT
dpc-1006	11	39	while	while	SCONJ
dpc-1006	11	40	anti	anti	ADJ
dpc-1006	11	41	-	-	ADJ
dpc-1006	11	42	dsg3	dsg3	ADJ
dpc-1006	11	43	was	be	AUX
dpc-1006	11	44	negative	negative	ADJ
dpc-1006	11	45	.	.	PUNCT
dpc-1006	12	1	in	in	ADP
dpc-1006	12	2	june	june	PROPN
dpc-1006	12	3	2018	2018	NUM
dpc-1006	12	4	a	a	DET
dpc-1006	12	5	surgical	surgical	ADJ
dpc-1006	12	6	procedure	procedure	NOUN
dpc-1006	12	7	was	be	AUX
dpc-1006	12	8	performed	perform	VERB
dpc-1006	12	9	in	in	ADP
dpc-1006	12	10	an	an	DET
dpc-1006	12	11	attempt	attempt	NOUN
dpc-1006	12	12	to	to	PART
dpc-1006	12	13	treat	treat	VERB
dpc-1006	12	14	femoral	femoral	ADJ
dpc-1006	12	15	avascular	avascular	ADJ
dpc-1006	12	16	necrosis	necrosis	NOUN
dpc-1006	12	17	.	.	PUNCT
dpc-1006	13	1	despite	despite	SCONJ
dpc-1006	13	2	the	the	DET
dpc-1006	13	3	successful	successful	ADJ
dpc-1006	13	4	surgery	surgery	NOUN
dpc-1006	13	5	,	,	PUNCT
dpc-1006	13	6	after	after	ADP
dpc-1006	13	7	6	6	NUM
dpc-1006	13	8	weeks	week	NOUN
dpc-1006	13	9	new	new	ADJ
dpc-1006	13	10	lesions	lesion	NOUN
dpc-1006	13	11	appeared	appear	VERB
dpc-1006	13	12	on	on	ADP
dpc-1006	13	13	the	the	DET
dpc-1006	13	14	surgery	surgery	NOUN
dpc-1006	13	15	site	site	NOUN
dpc-1006	13	16	,	,	PUNCT
dpc-1006	13	17	which	which	PRON
dpc-1006	13	18	seemed	seem	VERB
dpc-1006	13	19	to	to	PART
dpc-1006	13	20	be	be	AUX
dpc-1006	13	21	related	relate	VERB
dpc-1006	13	22	to	to	ADP
dpc-1006	13	23	kp	kp	PROPN
dpc-1006	13	24	(	(	PUNCT
dpc-1006	13	25	figure	figure	NOUN
dpc-1006	13	26	1	1	NUM
dpc-1006	13	27	,	,	PUNCT
dpc-1006	13	28	a	a	PRON
dpc-1006	13	29	and	and	CCONJ
dpc-1006	13	30	b	b	NOUN
dpc-1006	13	31	)	)	PUNCT
dpc-1006	13	32	.	.	PUNCT
dpc-1006	14	1	at	at	ADP
dpc-1006	14	2	the	the	DET
dpc-1006	14	3	last	last	ADJ
dpc-1006	14	4	follow	follow	NOUN
dpc-1006	14	5	-	-	PUNCT
dpc-1006	14	6	up	up	NOUN
dpc-1006	14	7	in	in	ADP
dpc-1006	14	8	may	may	PROPN
dpc-1006	14	9	2019	2019	NUM
dpc-1006	14	10	,	,	PUNCT
dpc-1006	14	11	the	the	DET
dpc-1006	14	12	lesions	lesion	NOUN
dpc-1006	14	13	were	be	AUX
dpc-1006	14	14	about	about	ADJ
dpc-1006	14	15	to	to	PART
dpc-1006	14	16	disappear	disappear	VERB
dpc-1006	14	17	via	via	ADP
dpc-1006	14	18	low	low	ADJ
dpc-1006	14	19	-	-	PUNCT
dpc-1006	14	20	dose	dose	NOUN
dpc-1006	14	21	steroid	steroid	NOUN
dpc-1006	14	22	treatment	treatment	NOUN
dpc-1006	14	23	(	(	PUNCT
dpc-1006	14	24	figure	figure	NOUN
dpc-1006	14	25	2	2	NUM
dpc-1006	14	26	,	,	PUNCT
dpc-1006	14	27	a	a	PRON
dpc-1006	14	28	and	and	CCONJ
dpc-1006	14	29	b	b	NOUN
dpc-1006	14	30	)	)	PUNCT
dpc-1006	14	31	.	.	PUNCT
dpc-1006	15	1	conclusions	conclusion	NOUN
dpc-1006	15	2	in	in	ADP
dpc-1006	15	3	addition	addition	NOUN
dpc-1006	15	4	to	to	ADP
dpc-1006	15	5	several	several	ADJ
dpc-1006	15	6	suggested	suggest	VERB
dpc-1006	15	7	triggers	trigger	NOUN
dpc-1006	15	8	for	for	ADP
dpc-1006	15	9	pemphigus	pemphigus	NOUN
dpc-1006	15	10	,	,	PUNCT
dpc-1006	15	11	trauma	trauma	NOUN
dpc-1006	15	12	can	can	AUX
dpc-1006	15	13	trigger	trigger	VERB
dpc-1006	15	14	the	the	DET
dpc-1006	15	15	onset	onset	NOUN
dpc-1006	15	16	of	of	ADP
dpc-1006	15	17	new	new	ADJ
dpc-1006	15	18	lesions	lesion	NOUN
dpc-1006	15	19	in	in	ADP
dpc-1006	15	20	patients	patient	NOUN
dpc-1006	15	21	with	with	ADP
dpc-1006	15	22	pemphigus	pemphigus	PROPN
dpc-1006	15	23	.	.	PUNCT
dpc-1006	16	1	a	a	DET
dpc-1006	16	2	variety	variety	NOUN
dpc-1006	16	3	of	of	ADP
dpc-1006	16	4	procedures	procedure	NOUN
dpc-1006	16	5	from	from	ADP
dpc-1006	16	6	minor	minor	ADJ
dpc-1006	16	7	skin	skin	NOUN
dpc-1006	16	8	surköbner	surköbner	ADJ
dpc-1006	16	9	phenomenon	phenomenon	NOUN
dpc-1006	16	10	in	in	ADP
dpc-1006	16	11	a	a	DET
dpc-1006	16	12	rituximab	rituximab	NOUN
dpc-1006	16	13	-	-	PUNCT
dpc-1006	16	14	treated	treat	VERB
dpc-1006	16	15	pemphigus	pemphigus	NOUN
dpc-1006	16	16	patient	patient	NOUN
dpc-1006	16	17	:	:	PUNCT
dpc-1006	16	18	beware	beware	NOUN
dpc-1006	16	19	disease	disease	NOUN
dpc-1006	16	20	activity	activity	NOUN
dpc-1006	16	21	soheil	soheil	NOUN
dpc-1006	16	22	tavakolpour1	tavakolpour1	NOUN
dpc-1006	16	23	,	,	PUNCT
dpc-1006	16	24	hamidreza	hamidreza	PROPN
dpc-1006	16	25	mahmoudi1	mahmoudi1	NOUN
dpc-1006	16	26	,	,	PUNCT
dpc-1006	16	27	nika	nika	PROPN
dpc-1006	16	28	kianfar1	kianfar1	PROPN
dpc-1006	16	29	,	,	PUNCT
dpc-1006	16	30	shayan	shayan	PROPN
dpc-1006	16	31	dasdar1	dasdar1	PROPN
dpc-1006	16	32	,	,	PUNCT
dpc-1006	16	33	maryam	maryam	PROPN
dpc-1006	16	34	daneshpazhooh1	daneshpazhooh1	PROPN
dpc-1006	16	35	1	1	NUM
dpc-1006	16	36	autoimmune	autoimmune	ADJ
dpc-1006	16	37	bullous	bullous	ADJ
dpc-1006	16	38	diseases	disease	NOUN
dpc-1006	16	39	research	research	NOUN
dpc-1006	16	40	center	center	NOUN
dpc-1006	16	41	,	,	PUNCT
dpc-1006	16	42	tehran	tehran	PROPN
dpc-1006	16	43	university	university	PROPN
dpc-1006	16	44	of	of	ADP
dpc-1006	16	45	medical	medical	ADJ
dpc-1006	16	46	sciences	sciences	PROPN
dpc-1006	16	47	,	,	PUNCT
dpc-1006	16	48	tehran	tehran	PROPN
dpc-1006	16	49	,	,	PUNCT
dpc-1006	16	50	iran	iran	PROPN
dpc-1006	16	51	key	key	ADJ
dpc-1006	16	52	words	word	NOUN
dpc-1006	16	53	:	:	PUNCT
dpc-1006	16	54	pemphigus	pemphigus	NOUN
dpc-1006	16	55	vulgaris	vulgaris	NOUN
dpc-1006	16	56	,	,	PUNCT
dpc-1006	16	57	pemphigus	pemphigus	PROPN
dpc-1006	16	58	foliaceus	foliaceus	NOUN
dpc-1006	16	59	,	,	PUNCT
dpc-1006	16	60	köbner	köbner	PROPN
dpc-1006	16	61	phenomenon	phenomenon	NOUN
dpc-1006	16	62	,	,	PUNCT
dpc-1006	16	63	rituximab	rituximab	NOUN
dpc-1006	16	64	,	,	PUNCT
dpc-1006	16	65	surgery	surgery	NOUN
dpc-1006	16	66	citation	citation	NOUN
dpc-1006	16	67	:	:	PUNCT
dpc-1006	16	68	tavakolpour	tavakolpour	PROPN
dpc-1006	16	69	s	s	NOUN
dpc-1006	16	70	,	,	PUNCT
dpc-1006	16	71	mahmoudi	mahmoudi	ADJ
dpc-1006	16	72	h	h	NOUN
dpc-1006	16	73	,	,	PUNCT
dpc-1006	16	74	kianfar	kianfar	ADJ
dpc-1006	16	75	n	n	CCONJ
dpc-1006	16	76	,	,	PUNCT
dpc-1006	16	77	dasdar	dasdar	PROPN
dpc-1006	16	78	s	s	PROPN
dpc-1006	16	79	,	,	PUNCT
dpc-1006	16	80	daneshpazhooh	daneshpazhooh	PROPN
dpc-1006	16	81	m.	m.	PROPN
dpc-1006	16	82	köbner	köbner	PROPN
dpc-1006	16	83	phenomenon	phenomenon	NOUN
dpc-1006	16	84	in	in	ADP
dpc-1006	16	85	a	a	DET
dpc-1006	16	86	rituximab	rituximab	NOUN
dpc-1006	16	87	-	-	PUNCT
dpc-1006	16	88	treated	treat	VERB
dpc-1006	16	89	pemphigus	pemphigus	NOUN
dpc-1006	16	90	patient	patient	NOUN
dpc-1006	16	91	:	:	PUNCT
dpc-1006	16	92	beware	beware	VERB
dpc-1006	16	93	disease	disease	NOUN
dpc-1006	16	94	activity	activity	NOUN
dpc-1006	16	95	.	.	PUNCT
dpc-1006	17	1	dermatol	dermatol	NOUN
dpc-1006	17	2	pract	pract	PROPN
dpc-1006	17	3	concept	concept	NOUN
dpc-1006	17	4	.	.	PUNCT
dpc-1006	18	1	2019;9(4):320	2019;9(4):320	X
dpc-1006	18	2	-	-	SYM
dpc-1006	18	3	321	321	NUM
dpc-1006	18	4	.	.	PUNCT
dpc-1006	19	1	doi	doi	NOUN
dpc-1006	19	2	:	:	PUNCT
dpc-1006	19	3	https://doi.org/10.5826/dpc.0904a20	https://doi.org/10.5826/dpc.0904a20	NOUN
dpc-1006	19	4	accepted	accept	VERB
dpc-1006	19	5	:	:	PUNCT
dpc-1006	19	6	june	june	PROPN
dpc-1006	19	7	26	26	NUM
dpc-1006	19	8	,	,	PUNCT
dpc-1006	19	9	2019	2019	NUM
dpc-1006	19	10	;	;	PUNCT
dpc-1006	19	11	published	publish	VERB
dpc-1006	19	12	:	:	PUNCT
dpc-1006	19	13	october	october	PROPN
dpc-1006	19	14	31	31	NUM
dpc-1006	19	15	,	,	PUNCT
dpc-1006	19	16	2019	2019	NUM
dpc-1006	19	17	copyright	copyright	NOUN
dpc-1006	19	18	:	:	PUNCT
dpc-1006	20	1	©	©	PROPN
dpc-1006	20	2	2019	2019	NUM
dpc-1006	20	3	tavakolpour	tavakolpour	NUM
dpc-1006	20	4	et	et	NOUN
dpc-1006	20	5	 	 	SPACE
dpc-1006	20	6	al	al	PROPN
dpc-1006	20	7	.	.	PUNCT
dpc-1006	21	1	this	this	PRON
dpc-1006	21	2	is	be	AUX
dpc-1006	21	3	an	an	DET
dpc-1006	21	4	open	open	ADJ
dpc-1006	21	5	-	-	PUNCT
dpc-1006	21	6	access	access	NOUN
dpc-1006	21	7	article	article	NOUN
dpc-1006	21	8	distributed	distribute	VERB
dpc-1006	21	9	under	under	ADP
dpc-1006	21	10	the	the	DET
dpc-1006	21	11	terms	term	NOUN
dpc-1006	21	12	of	of	ADP
dpc-1006	21	13	the	the	DET
dpc-1006	21	14	creative	creative	ADJ
dpc-1006	21	15	commons	common	NOUN
dpc-1006	21	16	attribution	attribution	NOUN
dpc-1006	21	17	license	license	NOUN
dpc-1006	21	18	,	,	PUNCT
dpc-1006	21	19	which	which	PRON
dpc-1006	21	20	permits	permit	VERB
dpc-1006	21	21	unrestricted	unrestricted	ADJ
dpc-1006	21	22	use	use	NOUN
dpc-1006	21	23	,	,	PUNCT
dpc-1006	21	24	distribution	distribution	NOUN
dpc-1006	21	25	,	,	PUNCT
dpc-1006	21	26	and	and	CCONJ
dpc-1006	21	27	reproduction	reproduction	NOUN
dpc-1006	21	28	in	in	ADP
dpc-1006	21	29	any	any	DET
dpc-1006	21	30	medium	medium	NOUN
dpc-1006	21	31	,	,	PUNCT
dpc-1006	21	32	provided	provide	VERB
dpc-1006	21	33	the	the	DET
dpc-1006	21	34	original	original	ADJ
dpc-1006	21	35	author	author	NOUN
dpc-1006	21	36	and	and	CCONJ
dpc-1006	21	37	source	source	NOUN
dpc-1006	21	38	are	be	AUX
dpc-1006	21	39	credited	credit	VERB
dpc-1006	21	40	.	.	PUNCT
dpc-1006	22	1	funding	funding	NOUN
dpc-1006	22	2	:	:	PUNCT
dpc-1006	22	3	none	none	NOUN
dpc-1006	22	4	.	.	PUNCT
dpc-1006	23	1	competing	compete	VERB
dpc-1006	23	2	interests	interest	NOUN
dpc-1006	23	3	:	:	PUNCT
dpc-1006	23	4	the	the	DET
dpc-1006	23	5	authors	author	NOUN
dpc-1006	23	6	have	have	VERB
dpc-1006	23	7	no	no	DET
dpc-1006	23	8	conflicts	conflict	NOUN
dpc-1006	23	9	of	of	ADP
dpc-1006	23	10	interest	interest	NOUN
dpc-1006	23	11	to	to	PART
dpc-1006	23	12	disclose	disclose	VERB
dpc-1006	23	13	.	.	PUNCT
dpc-1006	24	1	authorship	authorship	NOUN
dpc-1006	24	2	:	:	PUNCT
dpc-1006	24	3	all	all	DET
dpc-1006	24	4	authors	author	NOUN
dpc-1006	24	5	have	have	AUX
dpc-1006	24	6	contributed	contribute	VERB
dpc-1006	24	7	significantly	significantly	ADV
dpc-1006	24	8	to	to	ADP
dpc-1006	24	9	this	this	DET
dpc-1006	24	10	publication	publication	NOUN
dpc-1006	24	11	.	.	PUNCT
dpc-1006	25	1	corresponding	correspond	VERB
dpc-1006	25	2	author	author	NOUN
dpc-1006	25	3	:	:	PUNCT
dpc-1006	25	4	hamidreza	hamidreza	PROPN
dpc-1006	25	5	mahmoudi	mahmoudi	PROPN
dpc-1006	25	6	,	,	PUNCT
dpc-1006	25	7	md	md	PROPN
dpc-1006	25	8	,	,	PUNCT
dpc-1006	25	9	autoimmune	autoimmune	ADJ
dpc-1006	25	10	bullous	bullous	ADJ
dpc-1006	25	11	diseases	disease	NOUN
dpc-1006	25	12	research	research	NOUN
dpc-1006	25	13	center	center	NOUN
dpc-1006	25	14	,	,	PUNCT
dpc-1006	25	15	razi	razi	PROPN
dpc-1006	25	16	hospital	hospital	PROPN
dpc-1006	25	17	,	,	PUNCT
dpc-1006	25	18	vahdate	vahdate	ADJ
dpc-1006	25	19	-	-	PUNCT
dpc-1006	25	20	eslami	eslami	NOUN
dpc-1006	25	21	square	square	NOUN
dpc-1006	25	22	,	,	PUNCT
dpc-1006	25	23	11996	11996	NUM
dpc-1006	25	24	,	,	PUNCT
dpc-1006	25	25	tehran	tehran	PROPN
dpc-1006	25	26	,	,	PUNCT
dpc-1006	25	27	iran	iran	PROPN
dpc-1006	25	28	.	.	PUNCT
dpc-1006	26	1	email	email	NOUN
dpc-1006	26	2	:	:	PUNCT
dpc-1006	26	3	hr_mahmoody@yahoo.com	hr_mahmoody@yahoo.com	NOUN
dpc-1006	26	4	letter	letter	NOUN
dpc-1006	27	1	|	|	ADV
dpc-1006	27	2	dermatol	dermatol	ADJ
dpc-1006	27	3	pract	pract	NOUN
dpc-1006	27	4	concept	concept	NOUN
dpc-1006	27	5	2019;9(4):20	2019;9(4):20	NUM
dpc-1006	27	6	321	321	NUM
dpc-1006	27	7	ever	ever	ADV
dpc-1006	27	8	,	,	PUNCT
dpc-1006	27	9	if	if	SCONJ
dpc-1006	27	10	the	the	DET
dpc-1006	27	11	surgery	surgery	NOUN
dpc-1006	27	12	is	be	AUX
dpc-1006	27	13	urgent	urgent	ADJ
dpc-1006	27	14	and	and	CCONJ
dpc-1006	27	15	patient	patient	NOUN
dpc-1006	27	16	is	be	AUX
dpc-1006	27	17	not	not	PART
dpc-1006	27	18	in	in	ADP
dpc-1006	27	19	remission	remission	NOUN
dpc-1006	27	20	,	,	PUNCT
dpc-1006	27	21	increasing	increase	VERB
dpc-1006	27	22	the	the	DET
dpc-1006	27	23	dose	dose	NOUN
dpc-1006	27	24	of	of	ADP
dpc-1006	27	25	corticosteroid	corticosteroid	NOUN
dpc-1006	27	26	could	could	AUX
dpc-1006	27	27	probably	probably	ADV
dpc-1006	27	28	prevent	prevent	VERB
dpc-1006	27	29	kp	kp	NOUN
dpc-1006	27	30	or	or	CCONJ
dpc-1006	27	31	at	at	ADP
dpc-1006	27	32	least	least	ADJ
dpc-1006	27	33	mitigate	mitigate	VERB
dpc-1006	27	34	its	its	PRON
dpc-1006	27	35	risk	risk	NOUN
dpc-1006	27	36	.	.	PUNCT
dpc-1006	28	1	however	however	ADV
dpc-1006	28	2	,	,	PUNCT
dpc-1006	28	3	further	further	ADJ
dpc-1006	28	4	studies	study	NOUN
dpc-1006	28	5	are	be	AUX
dpc-1006	28	6	needed	need	VERB
dpc-1006	28	7	to	to	PART
dpc-1006	28	8	better	well	ADV
dpc-1006	28	9	understand	understand	VERB
dpc-1006	28	10	approaches	approach	NOUN
dpc-1006	28	11	for	for	ADP
dpc-1006	28	12	preventing	prevent	VERB
dpc-1006	28	13	kp	kp	NOUN
dpc-1006	28	14	in	in	ADP
dpc-1006	28	15	patients	patient	NOUN
dpc-1006	28	16	with	with	ADP
dpc-1006	28	17	pemphigus	pemphigus	PROPN
dpc-1006	28	18	.	.	PUNCT
dpc-1006	29	1	references	reference	NOUN
dpc-1006	29	2	1	1	NUM
dpc-1006	29	3	.	.	PUNCT
dpc-1006	30	1	balighi	balighi	PROPN
dpc-1006	30	2	k	k	PROPN
dpc-1006	30	3	,	,	PUNCT
dpc-1006	30	4	daneshpazhooh	daneshpazhooh	PROPN
dpc-1006	30	5	m	m	PRON
dpc-1006	30	6	,	,	PUNCT
dpc-1006	30	7	azizpour	azizpour	VERB
dpc-1006	30	8	a	a	PRON
dpc-1006	30	9	,	,	PUNCT
dpc-1006	30	10	et	et	PROPN
dpc-1006	30	11	 	 	SPACE
dpc-1006	30	12	al	al	PROPN
dpc-1006	30	13	.	.	PROPN
dpc-1006	30	14	koebner	koebner	PROPN
dpc-1006	30	15	phenomenon	phenomenon	NOUN
dpc-1006	30	16	in	in	ADP
dpc-1006	30	17	pemphigus	pemphigus	ADJ
dpc-1006	30	18	vulgaris	vulgaris	NOUN
dpc-1006	30	19	patients	patient	NOUN
dpc-1006	30	20	.	.	PUNCT
dpc-1006	31	1	jaad	jaad	NOUN
dpc-1006	31	2	case	case	NOUN
dpc-1006	31	3	rep	rep	PROPN
dpc-1006	31	4	.	.	PROPN
dpc-1006	31	5	2016;2(5):419	2016;2(5):419	NUM
dpc-1006	31	6	-	-	SYM
dpc-1006	31	7	421	421	NUM
dpc-1006	31	8	.	.	NOUN
dpc-1006	32	1	2	2	X
dpc-1006	32	2	.	.	X
dpc-1006	32	3	daneshpazhooh	daneshpazhooh	PROPN
dpc-1006	32	4	m	m	PROPN
dpc-1006	32	5	,	,	PUNCT
dpc-1006	32	6	fatehnejad	fatehnejad	PROPN
dpc-1006	32	7	m	m	PROPN
dpc-1006	32	8	,	,	PUNCT
dpc-1006	32	9	rahbar	rahbar	NOUN
dpc-1006	32	10	z	z	PROPN
dpc-1006	32	11	,	,	PUNCT
dpc-1006	32	12	et	et	PROPN
dpc-1006	32	13	 	 	SPACE
dpc-1006	32	14	al	al	PROPN
dpc-1006	32	15	.	.	PUNCT
dpc-1006	32	16	trauma	trauma	NOUN
dpc-1006	32	17	-	-	PUNCT
dpc-1006	32	18	induced	induce	VERB
dpc-1006	32	19	pemphigus	pemphigus	NOUN
dpc-1006	32	20	:	:	PUNCT
dpc-1006	32	21	a	a	DET
dpc-1006	32	22	case	case	NOUN
dpc-1006	32	23	series	series	NOUN
dpc-1006	32	24	of	of	ADP
dpc-1006	32	25	36	36	NUM
dpc-1006	32	26	patients	patient	NOUN
dpc-1006	32	27	.	.	PUNCT
dpc-1006	33	1	j	j	PROPN
dpc-1006	33	2	dtsch	dtsch	PROPN
dpc-1006	33	3	dermatol	dermatol	NOUN
dpc-1006	33	4	ges	ge	NOUN
dpc-1006	33	5	.	.	PUNCT
dpc-1006	34	1	2016;14(2):166	2016;14(2):166	NUM
dpc-1006	34	2	-	-	PUNCT
dpc-1006	34	3	171	171	NUM
dpc-1006	34	4	.	.	PUNCT
dpc-1006	35	1	geries	gerie	NOUN
dpc-1006	35	2	to	to	ADP
dpc-1006	35	3	major	major	ADJ
dpc-1006	35	4	abdominal	abdominal	ADJ
dpc-1006	35	5	and	and	CCONJ
dpc-1006	35	6	thoracic	thoracic	NOUN
dpc-1006	35	7	surgeries	surgery	NOUN
dpc-1006	35	8	have	have	AUX
dpc-1006	35	9	been	be	AUX
dpc-1006	35	10	reported	report	VERB
dpc-1006	35	11	as	as	ADP
dpc-1006	35	12	triggers	trigger	NOUN
dpc-1006	35	13	of	of	ADP
dpc-1006	35	14	kp	kp	PROPN
dpc-1006	35	15	in	in	ADP
dpc-1006	35	16	pemphigus	pemphigus	PROPN
dpc-1006	35	17	.	.	PUNCT
dpc-1006	36	1	however	however	ADV
dpc-1006	36	2	,	,	PUNCT
dpc-1006	36	3	the	the	DET
dpc-1006	36	4	number	number	NOUN
dpc-1006	36	5	of	of	ADP
dpc-1006	36	6	reported	report	VERB
dpc-1006	36	7	cases	case	NOUN
dpc-1006	36	8	is	be	AUX
dpc-1006	36	9	too	too	ADV
dpc-1006	36	10	small	small	ADJ
dpc-1006	36	11	to	to	PART
dpc-1006	36	12	draw	draw	VERB
dpc-1006	36	13	any	any	DET
dpc-1006	36	14	conclusion	conclusion	NOUN
dpc-1006	36	15	about	about	ADP
dpc-1006	36	16	the	the	DET
dpc-1006	36	17	pathogenesis	pathogenesis	NOUN
dpc-1006	36	18	of	of	ADP
dpc-1006	36	19	kp	kp	PROPN
dpc-1006	36	20	.	.	PUNCT
dpc-1006	37	1	the	the	DET
dpc-1006	37	2	reported	report	VERB
dpc-1006	37	3	mean	mean	ADJ
dpc-1006	37	4	interval	interval	NOUN
dpc-1006	37	5	between	between	ADP
dpc-1006	37	6	trauma	trauma	NOUN
dpc-1006	37	7	and	and	CCONJ
dpc-1006	37	8	the	the	DET
dpc-1006	37	9	development	development	NOUN
dpc-1006	37	10	of	of	ADP
dpc-1006	37	11	lesions	lesion	NOUN
dpc-1006	37	12	was	be	AUX
dpc-1006	37	13	approximately	approximately	ADV
dpc-1006	37	14	5	5	NUM
dpc-1006	37	15	weeks	week	NOUN
dpc-1006	37	16	[	[	X
dpc-1006	37	17	2	2	NUM
dpc-1006	37	18	]	]	PUNCT
dpc-1006	37	19	.	.	PUNCT
dpc-1006	38	1	in	in	ADP
dpc-1006	38	2	our	our	PRON
dpc-1006	38	3	patient	patient	NOUN
dpc-1006	38	4	,	,	PUNCT
dpc-1006	38	5	the	the	DET
dpc-1006	38	6	disease	disease	NOUN
dpc-1006	38	7	was	be	AUX
dpc-1006	38	8	both	both	PRON
dpc-1006	38	9	clinically	clinically	ADV
dpc-1006	38	10	and	and	CCONJ
dpc-1006	38	11	serologically	serologically	ADV
dpc-1006	38	12	active	active	ADJ
dpc-1006	38	13	at	at	ADP
dpc-1006	38	14	the	the	DET
dpc-1006	38	15	time	time	NOUN
dpc-1006	38	16	of	of	ADP
dpc-1006	38	17	surgery	surgery	NOUN
dpc-1006	38	18	,	,	PUNCT
dpc-1006	38	19	which	which	PRON
dpc-1006	38	20	might	might	AUX
dpc-1006	38	21	be	be	AUX
dpc-1006	38	22	a	a	DET
dpc-1006	38	23	risk	risk	NOUN
dpc-1006	38	24	factor	factor	NOUN
dpc-1006	38	25	for	for	ADP
dpc-1006	38	26	kp	kp	NOUN
dpc-1006	38	27	.	.	PUNCT
dpc-1006	39	1	in	in	ADP
dpc-1006	39	2	general	general	ADJ
dpc-1006	39	3	,	,	PUNCT
dpc-1006	39	4	unnecessary	unnecessary	ADJ
dpc-1006	39	5	surgery	surgery	NOUN
dpc-1006	39	6	and	and	CCONJ
dpc-1006	39	7	blunt	blunt	ADJ
dpc-1006	39	8	trauma	trauma	NOUN
dpc-1006	39	9	should	should	AUX
dpc-1006	39	10	be	be	AUX
dpc-1006	39	11	avoided	avoid	VERB
dpc-1006	39	12	in	in	ADP
dpc-1006	39	13	patients	patient	NOUN
dpc-1006	39	14	with	with	ADP
dpc-1006	39	15	pemphigus	pemphigus	NOUN
dpc-1006	39	16	[	[	X
dpc-1006	39	17	2	2	NUM
dpc-1006	39	18	]	]	PUNCT
dpc-1006	39	19	.	.	PUNCT
dpc-1006	40	1	necessary	necessary	ADJ
dpc-1006	40	2	procedures	procedure	NOUN
dpc-1006	40	3	should	should	AUX
dpc-1006	40	4	be	be	AUX
dpc-1006	40	5	postponed	postpone	VERB
dpc-1006	40	6	if	if	SCONJ
dpc-1006	40	7	possible	possible	ADJ
dpc-1006	40	8	to	to	ADP
dpc-1006	40	9	a	a	DET
dpc-1006	40	10	time	time	NOUN
dpc-1006	40	11	when	when	SCONJ
dpc-1006	40	12	the	the	DET
dpc-1006	40	13	patient	patient	NOUN
dpc-1006	40	14	is	be	AUX
dpc-1006	40	15	both	both	PRON
dpc-1006	40	16	clinically	clinically	ADV
dpc-1006	40	17	and	and	CCONJ
dpc-1006	40	18	serologically	serologically	ADV
dpc-1006	40	19	in	in	ADP
dpc-1006	40	20	remission	remission	NOUN
dpc-1006	40	21	,	,	PUNCT
dpc-1006	40	22	to	to	PART
dpc-1006	40	23	minimize	minimize	VERB
dpc-1006	40	24	the	the	DET
dpc-1006	40	25	risk	risk	NOUN
dpc-1006	40	26	of	of	ADP
dpc-1006	40	27	kp	kp	PROPN
dpc-1006	40	28	.	.	PUNCT
dpc-1006	41	1	this	this	PRON
dpc-1006	41	2	could	could	AUX
dpc-1006	41	3	be	be	AUX
dpc-1006	41	4	achieved	achieve	VERB
dpc-1006	41	5	1	1	NUM
dpc-1006	41	6	-	-	SYM
dpc-1006	41	7	3	3	NUM
dpc-1006	41	8	months	month	NOUN
dpc-1006	41	9	after	after	ADP
dpc-1006	41	10	rtx	rtx	NOUN
dpc-1006	41	11	therapy	therapy	NOUN
dpc-1006	41	12	and	and	CCONJ
dpc-1006	41	13	usually	usually	ADV
dpc-1006	41	14	lasts	last	VERB
dpc-1006	41	15	for	for	ADP
dpc-1006	41	16	6	6	NUM
dpc-1006	41	17	-	-	SYM
dpc-1006	41	18	12	12	NUM
dpc-1006	41	19	months	month	NOUN
dpc-1006	41	20	.	.	PUNCT
dpc-1006	42	1	howfigure	howfigure	NOUN
dpc-1006	42	2	1	1	NUM
dpc-1006	42	3	.	.	PUNCT
dpc-1006	43	1	(	(	PUNCT
dpc-1006	43	2	a	a	X
dpc-1006	43	3	)	)	PUNCT
dpc-1006	43	4	pemphigus	pemphigus	NOUN
dpc-1006	43	5	foliaceus	foliaceus	ADJ
dpc-1006	43	6	lesions	lesion	NOUN
dpc-1006	43	7	on	on	ADP
dpc-1006	43	8	the	the	DET
dpc-1006	43	9	chest	chest	NOUN
dpc-1006	43	10	,	,	PUNCT
dpc-1006	43	11	representing	represent	VERB
dpc-1006	43	12	disease	disease	NOUN
dpc-1006	43	13	activity	activity	NOUN
dpc-1006	43	14	.	.	PUNCT
dpc-1006	44	1	(	(	PUNCT
dpc-1006	44	2	b	b	X
dpc-1006	44	3	)	)	PUNCT
dpc-1006	44	4	new	new	ADJ
dpc-1006	44	5	lesions	lesion	NOUN
dpc-1006	44	6	that	that	PRON
dpc-1006	44	7	developed	develop	VERB
dpc-1006	44	8	approximately	approximately	ADV
dpc-1006	44	9	6	6	NUM
dpc-1006	44	10	weeks	week	NOUN
dpc-1006	44	11	after	after	ADP
dpc-1006	44	12	hip	hip	NOUN
dpc-1006	44	13	surgery	surgery	NOUN
dpc-1006	44	14	suggest	suggest	VERB
dpc-1006	44	15	köbner	köbner	PROPN
dpc-1006	44	16	phenomenon	phenomenon	NOUN
dpc-1006	44	17	.	.	PUNCT
dpc-1006	45	1	[	[	X
dpc-1006	45	2	copyright	copyright	NOUN
dpc-1006	45	3	:	:	PUNCT
dpc-1006	45	4	©	©	PROPN
dpc-1006	45	5	2019	2019	NUM
dpc-1006	45	6	tavakolpour	tavakolpour	NUM
dpc-1006	45	7	et	et	NOUN
dpc-1006	45	8	 	 	SPACE
dpc-1006	45	9	al	al	PROPN
dpc-1006	45	10	.	.	PROPN
dpc-1006	45	11	]	]	PUNCT
dpc-1006	45	12	figure	figure	NOUN
dpc-1006	45	13	2	2	NUM
dpc-1006	45	14	.	.	PUNCT
dpc-1006	46	1	disappearance	disappearance	NOUN
dpc-1006	46	2	of	of	ADP
dpc-1006	46	3	all	all	DET
dpc-1006	46	4	skin	skin	NOUN
dpc-1006	46	5	lesions	lesion	NOUN
dpc-1006	46	6	on	on	ADP
dpc-1006	46	7	the	the	DET
dpc-1006	46	8	chest	chest	NOUN
dpc-1006	46	9	(	(	PUNCT
dpc-1006	46	10	a	a	NOUN
dpc-1006	46	11	)	)	PUNCT
dpc-1006	46	12	and	and	CCONJ
dpc-1006	46	13	hip	hip	NOUN
dpc-1006	46	14	(	(	PUNCT
dpc-1006	46	15	b	b	NOUN
dpc-1006	46	16	)	)	PUNCT
dpc-1006	46	17	,	,	PUNCT
dpc-1006	46	18	7	7	NUM
dpc-1006	46	19	months	month	NOUN
dpc-1006	46	20	after	after	ADP
dpc-1006	46	21	treatment	treatment	NOUN
dpc-1006	46	22	with	with	ADP
dpc-1006	46	23	low	low	ADV
dpc-1006	46	24	-	-	PUNCT
dpc-1006	46	25	dose	dose	NOUN
dpc-1006	46	26	prednisolone	prednisolone	PROPN
dpc-1006	46	27	(	(	PUNCT
dpc-1006	46	28	<	<	X
dpc-1006	46	29	10	10	NUM
dpc-1006	46	30	mg	mg	NUM
dpc-1006	46	31	/	/	SYM
dpc-1006	46	32	d	d	NOUN
dpc-1006	46	33	)	)	PUNCT
dpc-1006	46	34	.	.	PUNCT
dpc-1006	47	1	[	[	X
dpc-1006	47	2	copyright	copyright	NOUN
dpc-1006	47	3	:	:	PUNCT
dpc-1006	47	4	©	©	PROPN
dpc-1006	47	5	2019	2019	NUM
dpc-1006	47	6	tavakolpour	tavakolpour	NUM
dpc-1006	47	7	et	et	NOUN
dpc-1006	47	8	 	 	SPACE
dpc-1006	47	9	al	al	PROPN
dpc-1006	47	10	.	.	PROPN
dpc-1006	47	11	]	]	PUNCT
